To cite the product, applicants and awardees must include the Digital Object Identifier and the Object type (e.g. preprint, protocol) in the citation. Also list any information about the document version (e.g. most recent date modified), and if relevant, the date the product was cited.
Example: Bar DZ, Atkatsh K, Tavarez U, Erdos MR, Gruenbaum Y, Collins FS. Biotinylation by antibody recognition- A novel method for proximity labeling. BioRxiv 069187 [Preprint]. August 11, 2016 [cited 2017 Jan 12]. Available from: https://doi.org/10.1101/069187.
Author(s)-Last name Initial(s), Last name initial(s). Title. Database number [Preprint]. Month day, year [cited year MO DY]. Available from: https://doi.org/number.
Taken from https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-050.html
The NIH requires specific minimum acknowledgements and levels of public license when deipositing Interim Research Products. These requirements include:
"NIH intends to maximize impact of interim research products that are developed with NIH funds. Therefore, NIH expects awardees to ensure a high level of public access to NIH supported interim products. To facilitate text mining and other analysis of these products as data, the NIH expects standardized terms of use. NIH also expects awardees will adhere to other norms of responsible scientific communication.
Specifically, to claim an interim research product as a product of an NIH award, the NIH expects that the awardee will:
For applications submitted for the May 25, 2017 due date and thereafter, awardees can claim these products on their progress report publication list. They can also report them on their RPPR as of May 25, 2017, and link them to their award in their My Bibliography account."
Taken from https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-050.html
The NIH allows the citing of Interim Research Products anywhere other research products are cited.
NIH forms include the list below: